INTRODUCTION
============

The definition of eosinophilic esophagitis (EoE) is based on the detection of an infiltrate with at least 15 eosinophils/high-power field (HPF) in a biopsy of esophageal mucosa, combined with symptoms of esophageal dysfunction and exclusion of other causes of eosinophilia \[[@b1-ce-2017-166]-[@b3-ce-2017-166]\].

The increasing prevalence of EoE may be partly explained by recent research aimed at diagnosis or a change in pathogenic mechanisms \[[@b4-ce-2017-166]-[@b6-ce-2017-166]\]. The highly-variable prevalence appears to be dependent on study population characteristics. The overall prevalence of EoE is low (0.05%--0.4%), but is reportedly as high as 15% in patients with dysphagia and 48% in patients with food bolus impaction \[[@b7-ce-2017-166]-[@b13-ce-2017-166]\].

Symptoms frequently associated with EoE are food impaction, dysphagia, and allergic disorders such as bronchial asthma. Endoscopic findings associated with EoE include mucosal edema, vertical furrows, concentric rings, whitish exudates and/oresophageal strictures \[[@b14-ce-2017-166],[@b15-ce-2017-166]\]. Moreover, EoE can be associated with manifestations similar to gastroesophageal reflux disease (GERD), such as heartburn and regurgitation, in nearly 30% of cases \[[@b15-ce-2017-166]\].

The aim of our work was to determine EoE prevalence in patients with upper gastrointestinal (UGI) symptoms in our locality.

MATERIALS AND METHODS
=====================

This study included 218 of 476 patients with various UGI symptoms who received proton-pump inhibitor therapy for 2 months with no improvement and agreed to undergo esophagogastroduodenoscopy after providing written informed consent. Patients with collagen diseases (such as scleroderma) or Crohn's disease were excluded; all patients stopped proton-pump inhibitors and H~2~ blockers1month before endoscopy. Athorough medical history was recorded with emphasis on demographic data and UGI symptoms (e.g., dysphagia, heartburn, vomiting, anorexia, and epigastric pain, in addition to a history of weight loss). Complete blood testing, liver and renal function testing, and urine and stool analyses were performed in all patients. Upper endoscopies were performed in the endoscopy unit of our gastroenterology department. A special endoscopic information sheet prepared for our research was completed. Examination was performed by well-trained endoscopists for the detection of findings associated with EoE (exudate, edema, rings, furrows, and strictures). Endoscopic findings of other esophageal, gastric, or duodenal diseases were also reported.

Multiple biopsy samples were obtained from the upper, middle, and lower third of the esophagus, i.e., at 5, 10, and 15 cm above the gastroesophageal junction. Gastric and duodenal biopsy samples were obtained when indicated in patients with gastric lesions for the diagnosis of the cause of UGI symptoms and detection of other causes of EoE.

Pathological examination was performed using hematoxylin and eosin staining. Biopsies were processed and examined by a pathologist who was blinded to endoscopic and clinical data.

Diagnosis of EoE was defined as the presence of ≥15 eosinophils/HPF at any part of the esophagus \[[@b1-ce-2017-166]\]. In addition, the diagnosis was made in the presence of eosinophilic abscess, edema of the lamina propria, elongated papillae, and fibrosis in the absence of another cause for EoE. SPSS statistical software (Version 20.0) was used for analysis. *p*\<0.05 was considered statistically significant. Comparison between the study groups was performed using the chi-squared (χ^2^) test.

Ethics approval of the study
----------------------------

The study was approved by the Ethics Committee of El-Minia University; all protocols were in accordance with the 1975 Declaration of Helsinki.

RESULTS
=======

The mean age of all patients was 36.77±12.41 years (21--67 years); 128 (58.7%) were men and 90 (41.3%) were women. Fifty-three (24.3%) were smokers ([Table 1](#t1-ce-2017-166){ref-type="table"}).

Epigastric pain was reported in 138 patients (63.3%), vomiting in 105 (48.2%), dysphagia in 25 (11.5%), anorexia in 80 (36.7%), and heartburn in 109 (50%). A history of weight loss was reported by 34 patients (15.6%; [Table 1](#t1-ce-2017-166){ref-type="table"}).

Endoscopic findings were as follow: esophagitis, gastritis, and duodenitis in 28 patients (12.8%); esophagitis and gastritis in 28 (12.8%); non-GERD esophagitis in 37 (17%); gastritis in 34 (15.6%); GERD esophagitis in 21 (9.6%); esophageal mass in 5 (2.3%); hiatal hernia in 7 (3.2%); gastric mass in 4 (1.8%); gastric or duodenal ulcer in 10 (4.6%); and endoscopically diagnosed EoE in 6 (2.8%). Normal endoscopic findings were present in 38 patients (17.4%; [Table 2](#t2-ce-2017-166){ref-type="table"}).

The esophageal pathological findings were as follows: non-specific esophagitis in 47 (21.6%), GERD esophagitis in 34 (15.6%), and esophageal dysplasia in 6 (2.8%). Only 4 of 6 patients (1.8%) endoscopically diagnosed with EoE matched the histopathological findings of EoE (15 eosinophils/HPF), and 127 (58.3%) showed normal esophageal pathology (this number included many patients with non-esophageal findings). The diagnosis of EoE is based on clinicopathological findings in the absence of other causes of esophageal eosinophilia; we found EoE in 4 (1.8%) patients with UGI symptoms ([Table 2](#t2-ce-2017-166){ref-type="table"}).

The association of endoscopic findings and esophageal histopathology with the presenting UGI symptoms is shown in [Tables 3](#t3-ce-2017-166){ref-type="table"} and [4](#t4-ce-2017-166){ref-type="table"}.

The mean age of EoE patients (3 men and 1 woman) was 34.3±6.0 years. None were smokers and all had normal stomach and duodenal endoscopic findings. Among these 4 patients, 3 (75%) complained of dysphagia, and 2 (50%) complained of heartburn with or without vomiting, anorexia, or epigastric pain. Dysphagia as a presenting symptom occurred more significantly in patients with EoE than in those without EoE (*p*\<0.001; [Table 5](#t5-ce-2017-166){ref-type="table"}).

DISCUSSION
==========

EoE is likely when symptoms of esophageal dysfunction are present and is confirmed by an eosinophilic infiltrate in any part of the esophagus. A minimum of 15 eosinophils/HPF is required for a diagnosis of EoE \[[@b3-ce-2017-166]\]. The epidemiology of EoE varies; several studies have suggested that this is due to increasing incidence or more frequent recognition \[[@b5-ce-2017-166],[@b16-ce-2017-166]\].

The purpose of our study was to determine EoE prevalence in adults complaining of UGI symptoms in our locality and to identify the clinical manifestations.

Endoscopy identified 6 patients with EoE out of 218 with various UGI symptoms (2.8%), but only 4 of these 6 showed histopathology matching the diagnosis (1.8%). EoE prevalence ranges from 0.4% to 1.1% in the general population \[[@b12-ce-2017-166],[@b17-ce-2017-166]\] and to 3.3% in patients presenting with UGI symptoms \[[@b18-ce-2017-166]\] and is further increased to 10%--15% in patients presenting with dysphagia \[[@b19-ce-2017-166]-[@b21-ce-2017-166]\].

Male predominance of EoE was noted in \>75% of adult and child cases \[[@b22-ce-2017-166]\]. In our research, all EoE patients were younger than 40 years, and EoE was found in more men than women (3 men and 1 woman). These findings were similar to those reported by Veerappan et al. \[[@b13-ce-2017-166]\], who found that EoE is more common in men younger than 50 years. Another study found that among 41 EoE patients, the male:female ratio was 4:1, with average age at diagnosis of 45 years \[[@b23-ce-2017-166]\].

Endoscopic features of EoE may include mucosal edema, concentric rings, longitudinal furrows, strictures, white exudates or plaques, and pallor or decreased vasculature \[[@b16-ce-2017-166],[@b24-ce-2017-166]\]. We endoscopically diagnosed 6 patients with EoE, but only 4 (66.6%) had confirmed EoE on histopathology. One of the other 2 cases was diagnosed histopathologically with non-GERD esophagitis and the other was normal. In contrast, no EoE cases diagnosed histologically had conflicting endoscopic diagnoses.

EoE may be underestimated or missed on endoscopic examination \[[@b25-ce-2017-166],[@b26-ce-2017-166]\]. One study of histologically confirmed EoE reported that 8.8% of patients had no detectable endoscopic findings of EoE \[[@b16-ce-2017-166]\]. Another study reported normal endoscopic findings in 17% of histologically confirmed EoE cases \[[@b27-ce-2017-166]\]. Moreover, a study by Hunter et al. \[[@b18-ce-2017-166]\] found a normal esophageal endoscopic appearance in 2 of 3 histologically diagnosed EoE cases. Mackenzie et al. \[[@b10-ce-2017-166]\] found that 13/31 (42%) EoE patients did not have typical findings on endoscopy and might have been missed unless biopsies were taken.

Thus, even with a high index of suspicion, the presence or absence of endoscopic findings of EoE is inadequate to make a definitive diagnosis. Mucosal biopsy samples should be obtained routinely from any patient with EoE symptoms (unexplained dysphagia, refractory heartburn, or chest pain), regardless of the endoscopic findings. Histological examination of a mucosal biopsy is essential for the diagnosis of EoE \[[@b27-ce-2017-166],[@b28-ce-2017-166]\].

Although the small number of cases in our study may have prevented a definitive conclusion, the combined endoscopic and histopathologic findings are extremely important in the diagnosis of EoE.

Common presenting symptoms of EoE in adults include dysphagia, food impaction, and heartburn \[[@b28-ce-2017-166]\]. In our study, we similarly found that dysphagia was the most common presenting symptom of EoE, found in 3 patients (75%; *p*\<0.001). No EoE patients complained of weight loss. Similarly, other studies found that dysphagia was present in 64.0% \[[@b13-ce-2017-166]\] and in up to 89% of EoE patients \[[@b25-ce-2017-166]\]. Another study showed that the most common endoscopy indication in adults with EoE was dysphagia (70.1%), followed by GERD/heartburn (27.1%) \[[@b29-ce-2017-166]\]. The prevalence of EoE was 1.8% among patients presenting with UGI symptoms in El-Minia, Egypt. Dysphagia and refractory heartburn were the main presenting symptoms of EoE.

Combined endoscopic and histopathologic evaluation is important in the diagnosis of EoE.
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###### 

Demographic and Clinical Data of Patients

  Patients with UGI symptoms (*n*=218)              
  -------------------------------------- ---------- -------------
  Age                                    Range      (21--67)
                                         Mean±SD    36.77±12.41
  Age groups                             20-30 yr   90 (41.3%)
                                         30-40 yr   53 (24.3%)
                                         40-50 yr   30 (13.8%)
                                         50-60 yr   31 (14.2%)
                                         \>60 yr    14 (6.4%)
  Sex                                    M          128 (58.7%)
                                         F          90 (41.3%)
  Smoking                                No         165 (75.7%)
                                         Yes        53 (24.3%)
  Dysphagia                              No         193 (88.5%)
                                         Yes        25 (11.5%)
  Heart burn                             No         109 (50%)
                                         Yes        109 (50%)
  Vomiting                               No         113 (51.8%)
                                         Yes        105 (48.2%)
  Epigastric pain                        No         80 (36.7%)
                                         Yes        138 (63.3%)
  Weight loss                            No         184 (84.4%)
                                         Yes        34 (15.6%)
  Anorexia                               No         138 (63.3%)
                                         Yes        80 (36.7%)

UGI, upper gastrointestinal; SD, standard deviation.

###### 

Endoscopic and Oesophageal Histopathological Findings of Patients

  Patients with UGI symptoms (*n*=218)                                            
  -------------------------------------- ---------------------------------------- -------------
  Endoscopic findings                    Normal                                   38 (17.4%)
                                         Oesophagitis, gastritis and duodenitis   28 (12.8%)
                                         Oesophagitis and gastritis               28 (12.8%)
                                         Non-GERD oesophagitis                    37 (17%)
                                         Gastritis                                34 (15.6%)
                                         GERD oesophagitis                        21 (9.6%)
                                         Oesophageal mass                         5 (2.3%)
                                         Hiatus hernia                            7 (3.2%)
                                         Gastric mass                             4 (1.8%)
                                         Gastric or duodenal ulcer                10 (4.6%)
                                         EoE                                      6 (2.8%)
  Oesophageal pathological findings      Normal                                   127 (58.3%)
                                         Non-specific oesophagitis                47 (21.6%)
                                         GERD oesophagitis                        34 (15.6%)
                                         Oeosophageal carcinoma                   6 (2.8%)
                                         EoE                                      4 (1.8%)

UGI, upper gastrointestinal; GERD, gastroesophageal reflux disease; EoE, eosinophilic esophagitis.

###### 

Association between Presenting Symptoms & Smoking and the Endoscopic Findings in the Examined Patients

  Endoscopy finding                        Smoking   Dysphagia   Heart burn   Vomiting   Epigastric pain   Weight loss   Anorexia                                               
  ---------------------------------------- --------- ----------- ------------ ---------- ----------------- ------------- ---------- ------ ------- ------ ------ ------ ------- ------
  Normal                                   11/38     28.9        3/38         7.9        13/38             34.2          18/38      47.4   20/38   52.6   2/38   5.3    10/38   26.3
  Oesophagitis, gastritis and duodenitis   10/28     35.7        3/28         10.7       16/28             57.1          15/28      53.6   25/28   89.3   7/28   25     14/28   50
  Oesophagitis, gastritis                  7/28      25          1/28         3.6        14/28             50            13/28      46.4   17/28   60.7   0/28   0      7/28    25
  Non-GERD oesophagitis                    3/37      8.1         5/37         13.5       20/37             54.1          17/37      45.9   19/37   51.4   1/37   2.7    9/37    24.3
  Gastritis                                9/34      26.5        0/34         0          12/34             35.3          7/34       20.6   30/34   88.2   4/34   11.8   15/34   44.1
  GERD                                     8/21      38.1        2/21         9.5        18/21             85.7          16/21      76.2   12/21   57.1   4/21   19     7/21    33.3
  Oesophagitis, mass                       1/5       20          4/5          80         1/5               20            3/5        60     1/5     20     4/5    80     3/5     60
  Hiatus hernia                            1/7       14.3        3/7          42.9       7/7               100           6/7        85.7   1/7     14.3   2/7    28.6   2/7     28.6
  Gastric mass                             1/4       25          0/4          0          0/4               0             1/4        25     3/4     75     4/4    100    4/4     100
  Gastric ulcer                            1/10      10          0/10         0          4/10              40            7/10       70     9/10    90     6/10   60     6/10    60
  EoE                                      1/6       16.7        4/6          66.7       4/6               66.7          2/6        33.3   1/6     16.7   0/6    0      3/6     50

GERD, gastroesophageal reflux disease; EoE, eosinophilic esophagitis.

###### 

Association between Presenting Symptoms & Smoking and the Oesophageal Pathological Findings in the Examined Patients

  Oesophageal pathological findings   Smoking   Dysphagia   Heart burn   Vomiting   Epigastric pain   Weight loss   Anorexia                                                   
  ----------------------------------- --------- ----------- ------------ ---------- ----------------- ------------- ---------- ------ -------- ------ -------- ------ -------- ------
  Normal                              32/127    25.2        6/127        4.7        59/127            46.5          59/127     46.5   83/127   65.4   18/127   14.2   49/127   38.6
  Non-specific oesophagitis           11/47     23.4        6/47         12.8       27/47             57.4          21/47      44.7   29/47    61.7   6/47     12.8   15/47    31.9
  GERD oesophagitis                   8/34      23.5        5/34         14.7       20/34             58.8          20/34      58.8   23/34    67.6   5/34     14.7   11/34    32.4
  Oesophageal carcimona               2/6       33.3        5/6          83.3       1/6               16.7          4/6        66.7   2/6      33.3   5/6      83.3   4/6      66.7
  EoE                                 0/4       0           3/4          75         2/4               50            1/4        25     1/4      25     0/4      0      1/4      25

GERD, gastroesophageal reflux disease; EoE, eosinophilic esophagitis.

###### 

Comparison between Patients with and without EoE

  Oesophageal pathology   Smoking   Dysphagia   Heart burn   Vomiting   Epigastric pain   Weight loss   Anorexia                                                  
  ----------------------- --------- ----------- ------------ ---------- ----------------- ------------- ---------- ------ --------- ---- -------- ------ -------- ------
  Without EoE             53/214    24.8        22/214       10.3       107/214           50            104/214    48.6   137/214   64   34/214   15.9   79/214   36.9
  With EoE                0/4       0           3/4          75         2/4               50            1/4        25     1/4       25   0/4      0      1/4      25
  *p*-value               0.253     \<0.001     1.0          0.349      0.109             0.386         0.624                                                     

EoE, eosinophilic esophagitis.
